Trial Profile
A 13 day placebo- and reference-controlled, double-blind, monocentric, randomized, intraindividual comparative clinical phase IIa study, investigating the efficacy and tolerability of valrubicin cream 0.01 %, 0.1 % and 1 % in a panel of 24 patients with Psoriasis in a Psoriasis plaque test.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Valrubicin (Primary) ; Betamethasone valerate; Calcipotriol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Valderm
- 12 Aug 2011 New trial record